A pair of Israeli technical institutes, the Technion Research and Development Foundation and the Technion – Israel Institute of Technology, agreed to accept a stake in NovoCure (NSDQ:NVCR) as part of a settlement inked last year to avert a potential patent dispute. The parties agreed in February 2015 to resolve “certain potential intellectual property disputes” between […]